Pelagos Insurance Capital Limited PLGO
23.96
(0.04)
(0.17%)
as of 25 Sep
- Market cap
- $2.0B
- P/E
- 5.8×
Follow PLGO
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
5.91 | 5.07 | 8.78 | 0.00 |
+8 more quarters Free account |
P/S ratio |
0.82 | 0.72 | 0.83 | 0.74 | |
P/FCF ratio |
3.26 | 5.97 | 0.00 | 0.00 | |
P/Operating CF |
(77.57) | 6.48 | 9.08 | 12.21 | |
P/B ratio |
0.93 | 0.79 | 0.87 | 0.78 | |
Price to Tangible BV |
0.93 | 0.79 | 0.87 | 0.78 | |
EV/Sales |
0.90 | 0.64 | 0.67 | 0.64 | |
EV/EBITDA |
4.47 | 3.37 | 5.51 | 175.34 | |
EV/Operating CF |
3.58 | 5.21 | (4.10) | (3.23) | |
EV/FCF |
3.59 | 5.24 | (4.09) | (3.21) | |
Quick Ratio |
0.65 | 0.70 | 0.74 | 0.73 | |
Current Ratio |
0.65 | 0.70 | 0.74 | 0.73 | |
Net Debt/EBITDA |
3.02 | (1.91) | (2.68) | (1.42) | |
Debt/Assets |
5.15% | 6.15% | 6.78% | 6.75% | |
Debt/Equity |
0.32 | 0.37 | 0.35 | 0.35 | |
Asset Turnover |
0.19 | 0.19 | 0.21 | 0.21 | |
Operating CF/Net income |
(0.60) | 2.54 | 1.94 | 1.19 | |
Capex/Depreciation |
0.10 | 0.11 | 0.05 | 0.13 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
4.86% | 4.85% | 4.18% | 4.17% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.54% | 0.28% | 0.43% | 0.37% | |
Graham Net Nets |
(2.47) | (2.54) | (1.76) | (2.01) | |
Graham Number |
49.38 | 45.35 | 33.68 | 0.00 | |
Earnings Yield |
16.92% | 19.73% | 11.39% | (0.22%) | |
Free Cash Flow Yield |
30.65% | 16.75% | (19.71%) | (27.07%) | |
Revenue per Share |
7.70 | 6.57 | 5.66 | 6.25 | |
Operating CF per Share |
(0.31) | 2.95 | 2.16 | 1.49 | |
Capex per Share |
0.00 | 0.00 | 0.00 | (0.01) | |
Free Cash Flow per Share |
(0.32) | 2.94 | 2.15 | 1.48 | |
Cash per Share |
6.13 | 11.42 | 11.75 | 10.43 | |
Shareholders Equity per Share |
26.30 | 24.25 | 22.60 | 23.15 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
26.30 | 24.25 | 22.60 | 23.15 | |
Free Cash Flow |
(26.70) | 273.60 | 228.60 | 154.60 | |
Working Capital |
(3,615.80) | (3,021.80) | (2,272.60) | (2,285.50) | |
Capital Expenditures |
(0.20) | (0.40) | (0.20) | (0.60) | |
Net Current Asset Value |
(5,087.20) | (4,505.20) | (3,665.30) | (3,804.10) | |
EV/EBIT |
4.35 | 3.25 | 5.18 | 55.50 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
6.83% | 17.69% | 19.60% | 20.02% | |
Price to Operating Income |
3.96 | 3.70 | 6.44 | 63.78 | |
| Other line items | |||||
Average Receivables |
5,803.05 | 5,632.85 | 4,801.80 | 4,798.50 | |
Average Payables |
9,755.75 | 9,642.50 | 8,488.95 | 8,274.45 | |
Average Assets |
13,493.50 | 13,241.35 | 12,104.85 | 12,087.85 | |
Average Common Equity |
2,271.95 | 2,322.65 | 2,424.00 | 2,524.20 |
Columns are period end dates